The role of VEGF/sVEGFR-2 serum ratio as biomarker angiogenesis in chronic liver disease and hepatocellular carcinoma

被引：0
|
作者：
Ratnasari, Neneng [1 ]
Nurdjanah, Siti [1 ]
Sadewa, Ahmad Hamim [1 ]
Hakimi, Mohammad Hakimi Mohammad [1 ]
机构：
[1] Gadjah Mada Univ, Fac Med, Yogyakarta, Indonesia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2014年 / 29卷
关键词：
ratio VEGF/sVEGFR-2; biomarker angiogenesis; chronic liver disease; hepatocellular carcinoma;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
O-044
引用
收藏
页码：18 / 18
页数：1
相关论文
共 50 条
  • [1] Implication of VEGF receptor soluble forms, sVEGFR-1 and sVEGFR-2, in pathological angiogenesis
    Lorquet, S.
    Pequeux, C.
    Berndt, S.
    Van den Brule, F.
    Foidart, J. M.
    Munaut, C.
    HUMAN REPRODUCTION, 2007, 22 : I174 - I175
  • [2] The effect of antipsychotic drug treatment on serum VEGF, sVEGFR-1, and sVEGFR-2 level in schizophrenia
    Kim, D. H.
    Kim, T. H.
    Lee, S. K.
    Son, B. K.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 144 - 144
  • [3] Monitoring of VEGF165 and sVEGFR-2 levels in normal and cancer serum and plasma
    Bradley, Stephen
    Hamer, Peter
    Cesarino, David
    Pennisi, Matthew
    Loesch, Eric
    Miller, Lauren
    Carney, Walter
    CANCER RESEARCH, 2009, 69
  • [4] Overweight and obesity versus concentrations of VEGF-A, sVEGFR-1, and sVEGFR-2 in plasma of patients with lower limb chronic ischemia
    Wieczor, Radoslaw
    Wieczor, Anna Maria
    Gadomska, Grazyna
    Stankowska, Katarzyna
    Fabisiak, Jacek
    Suppan, Karol
    Pulkowski, Grzegorz
    Budzynski, Jacek
    Rosc, Danuta
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2016, 17 (11): : 842 - 849
  • [5] The effect of antipsychotic drug treatment on serum levels of vascular endothelial growth factor (VEGF), sVEGFR-1, and sVEGFR-2 in schizophrenia
    Kim, D. H.
    Sohn, B. K.
    Lee, S. K.
    Moon, Y. S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S332 - S333
  • [6] Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease
    Zinkin, Noah T.
    Grall, Franck
    Bhaskar, Killimangalam
    Otu, Hasan H.
    Spentzos, Dimitrios
    Kalmowitz, Brett
    Wells, Meghan
    Guerrero, Manuel
    Asara, John M.
    Libermann, Towia A.
    Afdhal, Nezam H.
    CLINICAL CANCER RESEARCH, 2008, 14 (02) : 470 - 477
  • [7] Angiogenesis: From Chronic Liver Inflammation to Hepatocellular Carcinoma
    Sanz-Cameno, Paloma
    Trapero-Marugan, Maria
    Chaparro, Maria
    Anthony Jones, Evan
    Moreno-Otero, Ricardo
    JOURNAL OF ONCOLOGY, 2010, 2010
  • [8] Role of Ultrasound for Chronic Liver Disease and Hepatocellular Carcinoma Surveillance
    Choi, Hailey H.
    Rodgers, Shuchi K.
    Khurana, Aman
    Nelson, Leslie W.
    Kamaya, Aya
    MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA, 2021, 29 (03) : 279 - 290
  • [9] Serum fucosylated haptoglobin in chronic liver diseases as a potential biomarker of hepatocellular carcinoma development
    Asazawa, Hitomi
    Kamada, Yoshihiro
    Takeda, Yuri
    Takamatsu, Shinji
    Shinzaki, Shinichiro
    Kim, Youkoku
    Nezu, Riichiro
    Kuzushita, Noriyoshi
    Mita, Eiji
    Kato, Michio
    Miyoshi, Eiji
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2015, 53 (01) : 95 - 102
  • [10] THE ROLE OF TGF-β2 IN CHRONIC LIVER DISEASE (CLD) AND HEPATOCELLULAR CARCINOMA (HCC)
    Dropmann, A.
    Dediulia, T.
    Weber, S.
    Abshagen, K.
    Wieland, M.
    Nittka, S.
    Breitkopf-Heinlein, K.
    Korhonen, H.
    Jaschinski, F.
    Janicot, M.
    Meindl-Beinker, N.
    Dooley, S.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S271 - S271
12345